Company page
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. is a public company traded under the ticker AGIO in the American market. The company has a market capitalization of approximately $2.03 billion. Agios focuses on developing innovative therapies for patients with cancer and rare genetic diseases.
- Ticker
- AGIO:NASDAQ
- Asset type
- Stock
- Market cap
- $2.03B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD